These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31036034)

  • 1. Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls.
    Boldrini L; Cusumano D; Cellini F; Azario L; Mattiucci GC; Valentini V
    Radiat Oncol; 2019 Apr; 14(1):71. PubMed ID: 31036034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
    Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
    Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing the Toxicity of Radiotherapy for Pancreatic Cancer With Magnetic Resonance-guided Radiotherapy.
    Tchelebi LT; Zaorsky NG; Rosenberg JC; Sharma NK; Tuanquin LC; Mackley HB; Ellis RJ
    Toxicol Sci; 2020 May; 175(1):19-23. PubMed ID: 32053201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
    Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
    Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of patients with locally advanced pancreatic cancer benefitting from plan adaptation in MR-guided radiation therapy.
    Bohoudi O; Bruynzeel AME; Meijerink MR; Senan S; Slotman BJ; Palacios MA; Lagerwaard FJ
    Radiother Oncol; 2019 Mar; 132():16-22. PubMed ID: 30825964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience.
    Garcia Schüler HI; Pavic M; Mayinger M; Weitkamp N; Chamberlain M; Reiner C; Linsenmeier C; Balermpas P; Krayenbühl J; Guckenberger M; Baumgartl M; Wilke L; Tanadini-Lang S; Andratschke N
    Radiat Oncol; 2021 Nov; 16(1):217. PubMed ID: 34775998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy.
    Tyran M; Jiang N; Cao M; Raldow A; Lamb JM; Low D; Luterstein E; Steinberg ML; Lee P
    Radiother Oncol; 2018 Nov; 129(2):319-325. PubMed ID: 30174107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial Intelligence in magnetic Resonance guided Radiotherapy: Medical and physical considerations on state of art and future perspectives.
    Cusumano D; Boldrini L; Dhont J; Fiorino C; Green O; Güngör G; Jornet N; Klüter S; Landry G; Mattiucci GC; Placidi L; Reynaert N; Ruggieri R; Tanadini-Lang S; Thorwarth D; Yadav P; Yang Y; Valentini V; Verellen D; Indovina L
    Phys Med; 2021 May; 85():175-191. PubMed ID: 34022660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical physics challenges in clinical MR-guided radiotherapy.
    Kurz C; Buizza G; Landry G; Kamp F; Rabe M; Paganelli C; Baroni G; Reiner M; Keall PJ; van den Berg CAT; Riboldi M
    Radiat Oncol; 2020 May; 15(1):93. PubMed ID: 32370788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technical Radiotherapy Advances - The Role of Magnetic Resonance Imaging-Guided Radiation in the Delivery of Hypofractionation.
    Gough J; Hall W; Good J; Nash A; Aitken K
    Clin Oncol (R Coll Radiol); 2022 May; 34(5):301-312. PubMed ID: 35305888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta radiomics analysis of Magnetic Resonance guided radiotherapy imaging data can enable treatment response prediction in pancreatic cancer.
    Tomaszewski MR; Latifi K; Boyer E; Palm RF; El Naqa I; Moros EG; Hoffe SE; Rosenberg SA; Frakes JM; Gillies RJ
    Radiat Oncol; 2021 Dec; 16(1):237. PubMed ID: 34911546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abdominal, multi-organ, auto-contouring method for online adaptive magnetic resonance guided radiotherapy: An intelligent, multi-level fusion approach.
    Liang F; Qian P; Su KH; Baydoun A; Leisser A; Van Hedent S; Kuo JW; Zhao K; Parikh P; Lu Y; Traughber BJ; Muzic RF
    Artif Intell Med; 2018 Aug; 90():34-41. PubMed ID: 30054121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric effect of the intestinal gas of online adaptive stereotactic body radiotherapy on target and critical organs without online electron density correction for pancreatic cancer.
    Su C; Okamoto H; Nishioka S; Sakasai T; Fujiyama D; Miura Y; Tsunoda Y; Kuwahara J; Nakamura S; Iijima K; Chiba T; Kaga K; Takemori M; Nakayama H; Katsuta S; Inaba K; Igaki H; Nakayama Y; Itami J
    Br J Radiol; 2021 Mar; 94(1119):20200239. PubMed ID: 33353402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR-guidance in clinical reality: current treatment challenges and future perspectives.
    Corradini S; Alongi F; Andratschke N; Belka C; Boldrini L; Cellini F; Debus J; Guckenberger M; Hörner-Rieber J; Lagerwaard FJ; Mazzola R; Palacios MA; Philippens MEP; Raaijmakers CPJ; Terhaard CHJ; Valentini V; Niyazi M
    Radiat Oncol; 2019 Jun; 14(1):92. PubMed ID: 31167658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer.
    Bohoudi O; Bruynzeel AME; Senan S; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Palacios MA
    Radiother Oncol; 2017 Dec; 125(3):439-444. PubMed ID: 28811038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and management of interfractional anatomic changes for pancreatic cancer radiotherapy.
    Liu F; Erickson B; Peng C; Li XA
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e423-9. PubMed ID: 22436785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR).
    Kim M; Schiff JP; Price A; Laugeman E; Samson PP; Kim H; Badiyan SN; Henke LE
    Radiat Oncol; 2022 Sep; 17(1):157. PubMed ID: 36100866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. End-to-end test of an online adaptive treatment procedure in MR-guided radiotherapy using a phantom with anthropomorphic structures.
    Elter A; Dorsch S; Mann P; Runz A; Johnen W; Spindeldreier CK; Klüter S; Karger CP
    Phys Med Biol; 2019 Nov; 64(22):225003. PubMed ID: 31610529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
    El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
    Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.